Chargement en cours...
Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies
Advancement in the understanding of cancer development in recent years has identified epigenetic abnormalities as a common factor in both tumorigenesis and refractory disease. One such event is the dysregulation of histone deacetylases (HDACs) in both hematological and solid tumors, and has conseque...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3000686/ https://ncbi.nlm.nih.gov/pubmed/21151768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph3082441 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|